This article has been updated to clarify that the test has not been cleared for use in a point-of-care setting.

NEW YORK (GenomeWeb News) – Canadian molecular diagnostics developer Spartan Bioscience said today that the US Food and Drug Administration has granted 510(k) clearance to the Spartan RX CYP2C19 assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.